Patent News For Altimmune Inc.
Altimmune Inc. ($ALT) shares traded sharply higher today after patent news. The company’s immunologic-therapeutic was granted a US patent today, potentially setting up the stock for an extended bull run. However, the company has a significant financial strain and no products at phase 3 status, so obtaining additional funding will be an issue. Here’s a […]
Read Article